Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_assertion type Assertion NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_head.
- NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_assertion wasGeneratedBy ECO_0000203 NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_provenance.
- NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_assertion wasDerivedFrom befree-20150227 NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_provenance.
- NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_assertion SIO_000772 11875368 NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_provenance.
- NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_assertion evidence source_evidence_literature NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_provenance.
- NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_assertion description "[In contrast, NAT2 genotype and CYP1A2 and NAT2 hepatic activity measured by caffeine urinary metabolites were not associated with adenoma risk, although an increase in risk with rapid CYP1A2 activity could not be ruled out (OR = 1.46; 95% CI 0.76-2.81).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339896.RASu7ZvgC3T_olXDGETiSC0btc9B50rpe6x9oROwWEweY130_provenance.